<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p50" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_50{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_50{left:341px;bottom:30px;}
#t3_50{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_50{left:377px;bottom:30px;}
#t5_50{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_50{left:540px;bottom:30px;}
#t7_50{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_50{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_50{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_50{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_50{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_50{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_50{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_50{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_50{left:1098px;bottom:28px;letter-spacing:0.32px;}
#tg_50{left:39px;bottom:183px;}
#th_50{left:49px;bottom:177px;letter-spacing:0.13px;}
#ti_50{left:264px;bottom:177px;}
#tj_50{left:39px;bottom:166px;}
#tk_50{left:45px;bottom:160px;letter-spacing:0.13px;word-spacing:-0.06px;}
#tl_50{left:339px;bottom:160px;}
#tm_50{left:39px;bottom:149px;}
#tn_50{left:45px;bottom:143px;letter-spacing:0.11px;word-spacing:0.01px;}
#to_50{left:48px;bottom:127px;letter-spacing:0.12px;}
#tp_50{left:654px;bottom:127px;letter-spacing:0.13px;}
#tq_50{left:733px;bottom:127px;}
#tr_50{left:738px;bottom:127px;}
#ts_50{left:39px;bottom:116px;}
#tt_50{left:48px;bottom:110px;letter-spacing:0.12px;word-spacing:-0.03px;}
#tu_50{left:558px;bottom:110px;}
#tv_50{left:36px;bottom:778px;letter-spacing:0.34px;word-spacing:-0.16px;}
#tw_50{left:265px;bottom:778px;letter-spacing:0.31px;word-spacing:-0.14px;}
#tx_50{left:265px;bottom:760px;letter-spacing:0.34px;word-spacing:-0.49px;}
#ty_50{left:540px;bottom:778px;letter-spacing:0.15px;}
#tz_50{left:540px;bottom:760px;letter-spacing:0.14px;}
#t10_50{left:741px;bottom:778px;letter-spacing:0.29px;}
#t11_50{left:741px;bottom:760px;letter-spacing:0.3px;}
#t12_50{left:929px;bottom:778px;letter-spacing:0.34px;}
#t13_50{left:1078px;bottom:562px;letter-spacing:-0.09px;}
#t14_50{left:1078px;bottom:544px;letter-spacing:-0.06px;}
#t15_50{left:1078px;bottom:526px;letter-spacing:-0.08px;}
#t16_50{left:1078px;bottom:507px;letter-spacing:-0.09px;}
#t17_50{left:1078px;bottom:489px;letter-spacing:-0.25px;}
#t18_50{left:933px;bottom:544px;letter-spacing:-0.1px;}
#t19_50{left:933px;bottom:526px;letter-spacing:-0.09px;}
#t1a_50{left:933px;bottom:507px;letter-spacing:-0.08px;}
#t1b_50{left:36px;bottom:521px;letter-spacing:-0.1px;}
#t1c_50{left:36px;bottom:503px;letter-spacing:-0.09px;}
#t1d_50{left:36px;bottom:485px;letter-spacing:-0.1px;word-spacing:-0.29px;}
#t1e_50{left:36px;bottom:466px;letter-spacing:-0.09px;}
#t1f_50{left:36px;bottom:448px;letter-spacing:-0.09px;}
#t1g_50{left:197px;bottom:455px;}
#t1h_50{left:205px;bottom:448px;}
#t1i_50{left:265px;bottom:565px;letter-spacing:-0.1px;}
#t1j_50{left:265px;bottom:547px;letter-spacing:-0.1px;}
#t1k_50{left:406px;bottom:554px;}
#t1l_50{left:265px;bottom:528px;letter-spacing:-0.1px;}
#t1m_50{left:265px;bottom:510px;letter-spacing:-0.1px;}
#t1n_50{left:265px;bottom:492px;letter-spacing:-0.08px;}
#t1o_50{left:265px;bottom:473px;letter-spacing:-0.1px;}
#t1p_50{left:265px;bottom:455px;letter-spacing:-0.1px;}
#t1q_50{left:348px;bottom:462px;}
#t1r_50{left:265px;bottom:430px;letter-spacing:-0.1px;}
#t1s_50{left:265px;bottom:404px;letter-spacing:-0.1px;}
#t1t_50{left:369px;bottom:412px;}
#t1u_50{left:533px;bottom:728px;letter-spacing:-0.1px;}
#t1v_50{left:533px;bottom:695px;letter-spacing:-0.09px;}
#t1w_50{left:533px;bottom:677px;letter-spacing:-0.09px;}
#t1x_50{left:533px;bottom:659px;letter-spacing:-0.09px;}
#t1y_50{left:533px;bottom:640px;letter-spacing:-0.09px;}
#t1z_50{left:599px;bottom:648px;}
#t20_50{left:533px;bottom:578px;letter-spacing:-0.09px;}
#t21_50{left:533px;bottom:559px;letter-spacing:-0.1px;}
#t22_50{left:533px;bottom:460px;letter-spacing:-0.09px;}
#t23_50{left:533px;bottom:441px;letter-spacing:-0.1px;}
#t24_50{left:533px;bottom:288px;letter-spacing:-0.09px;}
#t25_50{left:533px;bottom:269px;letter-spacing:-0.1px;}
#t26_50{left:741px;bottom:664px;letter-spacing:-0.11px;}
#t27_50{left:842px;bottom:672px;}
#t28_50{left:741px;bottom:636px;letter-spacing:-0.08px;}
#t29_50{left:741px;bottom:618px;letter-spacing:-0.08px;}
#t2a_50{left:741px;bottom:600px;letter-spacing:-0.09px;}
#t2b_50{left:741px;bottom:581px;letter-spacing:-0.06px;}
#t2c_50{left:741px;bottom:563px;letter-spacing:-0.13px;}
#t2d_50{left:765px;bottom:571px;}
#t2e_50{left:741px;bottom:545px;letter-spacing:-0.1px;}
#t2f_50{left:741px;bottom:526px;letter-spacing:-0.1px;}
#t2g_50{left:741px;bottom:508px;letter-spacing:-0.1px;}
#t2h_50{left:830px;bottom:516px;letter-spacing:-0.09px;}
#t2i_50{left:740px;bottom:483px;letter-spacing:-0.1px;}
#t2j_50{left:740px;bottom:465px;letter-spacing:-0.13px;}
#t2k_50{left:763px;bottom:472px;letter-spacing:-0.09px;}
#t2l_50{left:783px;bottom:465px;letter-spacing:-0.09px;}
#t2m_50{left:740px;bottom:447px;letter-spacing:-0.06px;}
#t2n_50{left:740px;bottom:428px;letter-spacing:-0.13px;}
#t2o_50{left:762px;bottom:436px;}
#t2p_50{left:770px;bottom:428px;letter-spacing:-0.09px;}
#t2q_50{left:740px;bottom:410px;letter-spacing:-0.09px;}
#t2r_50{left:739px;bottom:288px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t2s_50{left:739px;bottom:269px;letter-spacing:-0.1px;}
#t2t_50{left:828px;bottom:269px;letter-spacing:-0.09px;}
#t2u_50{left:863px;bottom:269px;letter-spacing:-0.11px;}
#t2v_50{left:533px;bottom:379px;letter-spacing:-0.09px;}
#t2w_50{left:533px;bottom:360px;letter-spacing:-0.09px;}
#t2x_50{left:533px;bottom:342px;letter-spacing:-0.09px;}
#t2y_50{left:533px;bottom:324px;letter-spacing:-0.09px;}
#t2z_50{left:599px;bottom:331px;}
#t30_50{left:739px;bottom:379px;letter-spacing:-0.13px;}
#t31_50{left:763px;bottom:386px;}
#t32_50{left:739px;bottom:360px;letter-spacing:-0.1px;}
#t33_50{left:739px;bottom:342px;letter-spacing:-0.1px;}
#t34_50{left:739px;bottom:324px;letter-spacing:-0.1px;}
#t35_50{left:829px;bottom:331px;letter-spacing:-0.09px;}
#t36_50{left:739px;bottom:232px;letter-spacing:-0.1px;}
#t37_50{left:739px;bottom:212px;letter-spacing:-0.09px;}
#t38_50{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_50{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_50{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_50{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_50{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_50{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_50{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_50{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_50{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_50{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_50{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sa_50{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_50{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_50{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts50" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg50Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg50" style="-webkit-user-select: none;"><object width="1210" height="935" data="50/50.svg" type="image/svg+xml" id="pdf50" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_50" class="t s0_50">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_50" class="t s1_50">® </span>
<span id="t3_50" class="t s0_50">(NCCN </span>
<span id="t4_50" class="t s1_50">® </span>
<span id="t5_50" class="t s0_50">), All rights reserved. NCCN Guidelines </span>
<span id="t6_50" class="t s1_50">® </span>
<span id="t7_50" class="t s0_50">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_50" class="t s2_50">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_50" class="t s2_50">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_50" class="t s3_50">NCCN Guidelines Version 4.2024 </span>
<span id="tb_50" class="t s3_50">Cancer of the Supraglottic Larynx </span>
<span id="tc_50" class="t s4_50">NCCN Guidelines Index </span>
<span id="td_50" class="t s4_50">Table of Contents </span>
<span id="te_50" class="t s4_50">Discussion </span>
<span id="tf_50" class="t s5_50">SUPRA-2 </span>
<span id="tg_50" class="t s6_50">h </span>
<span id="th_50" class="t s7_50">Principles of Surgery (SURG-A)</span><span id="ti_50" class="t s8_50">. </span>
<span id="tj_50" class="t s6_50">i </span>
<span id="tk_50" class="t s7_50">Principles of Radiation Therapy (SUPRA-A)</span><span id="tl_50" class="t s8_50">. </span>
<span id="tm_50" class="t s6_50">j </span>
<span id="tn_50" class="t s8_50">Adverse pathologic features: extranodal extension, positive margins, close margins, pT3 or pT4 primary, </span>
<span id="to_50" class="t s8_50">pN2 or pN3 nodal disease, perineural invasion, vascular invasion, and lymphatic invasion </span><span id="tp_50" class="t s7_50">(Discussion</span><span id="tq_50" class="t s8_50">)</span><span id="tr_50" class="t s7_50">. </span>
<span id="ts_50" class="t s6_50">k </span>
<span id="tt_50" class="t s7_50">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="tu_50" class="t s8_50">. </span>
<span id="tv_50" class="t s5_50">CLINICAL STAGING </span><span id="tw_50" class="t s5_50">TREATMENT OF </span>
<span id="tx_50" class="t s5_50">PRIMARY AND NECK </span>
<span id="ty_50" class="t s5_50">PATHOLOGY </span>
<span id="tz_50" class="t s5_50">STAGE </span>
<span id="t10_50" class="t s5_50">ADJUVANT </span>
<span id="t11_50" class="t s5_50">TREATMENT </span>
<span id="t12_50" class="t s5_50">FOLLOW-UP </span>
<span id="t13_50" class="t s5_50">Recurrent </span>
<span id="t14_50" class="t s5_50">or </span>
<span id="t15_50" class="t s5_50">persistent </span>
<span id="t16_50" class="t s5_50">disease </span>
<span id="t17_50" class="t s9_50">(ADV-3) </span>
<span id="t18_50" class="t s5_50">Follow-up </span>
<span id="t19_50" class="t s9_50">(FOLL-A, 1 </span>
<span id="t1a_50" class="t s9_50">of 2) </span>
<span id="t1b_50" class="t s5_50">Amenable to </span>
<span id="t1c_50" class="t s5_50">larynx-preserving </span>
<span id="t1d_50" class="t s5_50">(conservation) surgery </span>
<span id="t1e_50" class="t s5_50">(most T1–2,N0; </span>
<span id="t1f_50" class="t s5_50">selected T3 patients </span>
<span id="t1g_50" class="t sa_50">h </span>
<span id="t1h_50" class="t s5_50">) </span>
<span id="t1i_50" class="t s5_50">Endoscopic resection </span>
<span id="t1j_50" class="t s5_50">+ neck dissection </span>
<span id="t1k_50" class="t sa_50">h </span>
<span id="t1l_50" class="t s5_50">or </span>
<span id="t1m_50" class="t s5_50">Endoscopic or open </span>
<span id="t1n_50" class="t s5_50">partial </span>
<span id="t1o_50" class="t s5_50">laryngectomy + neck </span>
<span id="t1p_50" class="t s5_50">dissection </span>
<span id="t1q_50" class="t sa_50">h </span>
<span id="t1r_50" class="t s5_50">or </span>
<span id="t1s_50" class="t sb_50" data-mappings='[[2,"fi"]]'>Deﬁnitive RT </span>
<span id="t1t_50" class="t sa_50">i </span>
<span id="t1u_50" class="t s5_50">Node negative (T1–T2,N0) </span>
<span id="t1v_50" class="t s5_50">One positive node </span>
<span id="t1w_50" class="t s5_50">without other </span>
<span id="t1x_50" class="t s5_50">adverse pathologic </span>
<span id="t1y_50" class="t s5_50">features </span>
<span id="t1z_50" class="t sa_50">j </span>
<span id="t20_50" class="t s5_50">Positive node; </span>
<span id="t21_50" class="t s5_50">positive margin </span>
<span id="t22_50" class="t s5_50">Extranodal </span>
<span id="t23_50" class="t s5_50">extension </span>
<span id="t24_50" class="t s5_50">Node negative </span>
<span id="t25_50" class="t s5_50">(T3–T4a,N0) </span>
<span id="t26_50" class="t s5_50">Consider RT </span>
<span id="t27_50" class="t sa_50">i </span>
<span id="t28_50" class="t s5_50">Re-resection, if </span>
<span id="t29_50" class="t s5_50">feasible in highly </span>
<span id="t2a_50" class="t s5_50">selected patients </span>
<span id="t2b_50" class="t s5_50">or </span>
<span id="t2c_50" class="t s5_50">RT </span>
<span id="t2d_50" class="t sa_50">i </span>
<span id="t2e_50" class="t s5_50">or </span>
<span id="t2f_50" class="t s5_50">Consider systemic </span>
<span id="t2g_50" class="t s5_50">therapy/RT </span>
<span id="t2h_50" class="t sa_50">i,k </span>
<span id="t2i_50" class="t s5_50">Systemic therapy/ </span>
<span id="t2j_50" class="t s5_50">RT </span>
<span id="t2k_50" class="t sa_50">i,k </span>
<span id="t2l_50" class="t s5_50">(category 1) </span>
<span id="t2m_50" class="t s5_50">or </span>
<span id="t2n_50" class="t s5_50">RT </span>
<span id="t2o_50" class="t sa_50">i </span>
<span id="t2p_50" class="t s5_50">(category 2B, </span>
<span id="t2q_50" class="t s5_50">for select patients) </span>
<span id="t2r_50" class="t s5_50">Adjuvant Treatment </span>
<span id="t2s_50" class="t s9_50">(SUPRA-3) </span><span id="t2t_50" class="t s5_50">and </span><span id="t2u_50" class="t s9_50">(SUPRA-8) </span>
<span id="t2v_50" class="t s5_50">Positive node; </span>
<span id="t2w_50" class="t s5_50">Other adverse </span>
<span id="t2x_50" class="t s5_50">pathologic </span>
<span id="t2y_50" class="t s5_50">features </span>
<span id="t2z_50" class="t sa_50">j </span>
<span id="t30_50" class="t s5_50">RT </span>
<span id="t31_50" class="t sa_50">i </span>
<span id="t32_50" class="t s5_50">or </span>
<span id="t33_50" class="t s5_50">Consider systemic </span>
<span id="t34_50" class="t s5_50">therapy/RT </span>
<span id="t35_50" class="t sa_50">i,k </span>
<span id="t36_50" class="t s9_50">Post Systemic Therapy/RT or RT </span>
<span id="t37_50" class="t s9_50">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t38_50" class="t sc_50">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
